Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principle payments will eventually prevent the firm from borrow excessively.
In most industries, total debt may also include current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meaningful to compare total debt amounts between companies that operate within the same sector.
BristolMyers Total Debt Assessment
Based on latest financial disclosure BristolMyers Squibb Company has Total Debt of 7.22 B. This is 354.03% higher than that of Healthcare sector, and 41.08% higher than that of Drug Manufacturers - Major industry, The Total Debt for all stocks is 6.14% lower than the firm.
Filter other Stocks by Total Debt
BristolMyers Squibb Company is rated below average in total debt category among related companies. Total debt of Drug Manufacturers - Major industry is currently estimated at about 175.86 Billion. BristolMyers holds roughly 7.22 Billion in total debt claiming about 4% of equities under Drug Manufacturers - Major industry.
Follow BristolMyers Total Debt with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Other BristolMyers Fundamentals